Immunoglobulin G against nucleocapsid protein in COVID-19 home isolated patients and its relation to stress and emotional problems
5 affiliations
- 1Department of Preventive Medicine, West Medical District, Ministry of Health and Population, Alexandria, Egypt
- 2Department of Microbiology, High Institute of Public Health, Alexandria University, Alexandria, Egypt
- 3Department of Family Health, High Institute of Public Health, Alexandria University, Alexandria, Egypt
- 4Department of Biostatistics, High Institute of Public Health, Alexandria University, Alexandria, Egypt
- 5Family and Community Medicine Department, College of Medicine, King Khalid University, Abha, Saudi Arabia
Abstract
Background: The COVID-19 pandemic is among the most devastating global health crises, with rising mortality and widespread psychological effects such as anxiety, depression, and stress.
Methods: A longitudinal study was conducted in Alexandria on COVID-19 patients. Participants were tested for anti-SARS-CoV-2 N-IgG. Psychological status was assessed using the Depression, Anxiety and Stress Scale-21 (DASS-21) questionnaire, with follow-up conducted after three months.
Results: Anti-SARS-CoV-2 N-IgG was detected in 72 (71.3%) patients in the first sample, 16 (15.8%) in the second, and only one (0.9%) in the fifth. Most participants (68.3%) were positive within 15 days of symptom onset, while 5.8% seroconverted after 21 days. At baseline, depression, anxiety, and stress were reported in 43.6%, 55.4%, and 7.9% of patients, respectively. At the three-month follow-up, only 2.0% had depression, 3.0% anxiety, and none reported stress.
Conclusion: Most patients developed anti-SARS-CoV-2 N-IgG within 15 days of the onset of symptoms. Depression and stress were associated with delayed development of anti-SARS-CoV-2 N-IgG antibodies among home-isolated COVID-19 patients.
Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12879-026-14247-w.
Related
- Stereotactic radiosurgery for isolated intracranial immunoglobulin G4 disease: An illustrative case.
- Emotional Reactivity and Emotion Regulation in Relation to Health-Related Quality of Life After Burn Injury: A Cross-Sectional Observational Study.
- The reliability of the adverse childhood experiences questionnaire for late postpartum use in relation to maternal emotional health
- ADHD Presentations and Severity in Adults: Psychometric Profiles, Psychiatric Comorbidities, and Emotional Dysregulation in Relation to Psychiatric Hospitalization
- A real-world comparison of celiac tissue transglutaminase immunoglobulin A antibody levels in pediatric patients using two different diagnostic kits.
BibTeX
@article{mohamed2026immunoglobulin,
title = {{Immunoglobulin G against nucleocapsid protein in COVID-19 home isolated patients and its relation to stress and emotional problems}},
author = {Nehad H. Mohamed and Mona H. Hashish and Heba S. Selim and Medhat Attia and Shehata Farag Shehata and Marwa M. Fekry},
journal = {BMC Infectious Diseases},
year = {2026},
month = nov,
doi = {10.1186/s12879-026-14247-w},
url = {https://doi.org/10.1186/s12879-026-14247-w},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Immunoglobulin G against nucleocapsid protein in COVID-19 home isolated patients and its relation to stress and emotional problems
AU - Nehad H. Mohamed
AU - Mona H. Hashish
AU - Heba S. Selim
AU - Medhat Attia
AU - Shehata Farag Shehata
AU - Marwa M. Fekry
PY - 2026
DA - 2026/11/09
JO - BMC Infectious Diseases
DO - 10.1186/s12879-026-14247-w
UR - https://doi.org/10.1186/s12879-026-14247-w
AB - Background: The COVID-19 pandemic is among the most devastating global health crises, with rising mortality and widespread psychological effects such as anxiety, depression, and stress. Methods: A longitudinal study was conducted in Alexandria on COVID-19 patients. Participants were tested for anti-SARS-CoV-2 N-IgG. Psychological status was assessed using the Depression, Anxiety and Stress Scale-21 (DASS-21) questionnaire, with follow-up conducted after three months. Results: Anti-SARS-CoV-2 N-IgG was detected in 72 (71.3%) patients in the first sample, 16 (15.8%) in the second, and only one (0.9%) in the fifth. Most participants (68.3%) were positive within 15 days of symptom onset, while 5.8% seroconverted after 21 days. At baseline, depression, anxiety, and stress were reported in 43.6%, 55.4%, and 7.9% of patients, respectively. At the three-month follow-up, only 2.0% had depression, 3.0% anxiety, and none reported stress. Conclusion: Most patients developed anti-SARS-CoV-2 N-IgG within 15 days of the onset of symptoms. Depression and stress were associated with delayed development of anti-SARS-CoV-2 N-IgG antibodies among home-isolated COVID-19 patients. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12879-026-14247-w.
SN - 1471-2334
ER -